Torabi-Pour N, Nouri A M, Perrett D, Oliver R T
Uro/Oncology Research and Analytical Biochemistry Unit, The Royal Hospital Trust, Whitechapel, London E1 1BB, UK.
Biomed Chromatogr. 2000 Nov;14(7):483-8. doi: 10.1002/1099-0801(200011)14:7<483::AID-BMC997>3.0.CO;2-#.
HPLC was used in combination with immuno-bead separation technique for identification of an individual protein from a pool of proteins. This was carried out using an in-house monoclonal antibody (ATC2) specific for placental alkaline phosphatase (PLAP) as a primary antibody for conjugation to CNBr beads. The phosphatase activity (ALP) of PLAP was measured by colorimetric assay (MEDC). The data from this study has so far indicated that: 1. HPLC analysis of molecules following isolation with ATC2-conjugated beads showed high degree of purity. This could be achieved using protein mixtures prepared from lysates of tumour cell lines or tumour fragments. 2. HPLC-isolated PLAP maintained phosphatase activity. 3. Out of the four dissociation reagents used, diethyl amine (DEA) was found to be the best reagent for dissociation of antigen, ie PLAP, but not mAb from CNBr beads. 4. The profile of ALP activity was different for samples prepared from testis and kidney fragments, both in terms of the HPLC peak profile as well as the sensitivity. These data confirmed that the immuno-bead separation technique in conjunction with HPLC were powerful tools for identifying an individual protein from a pool of proteins. These approaches are being used for the identification of PLAP molecules, as a tumour marker in patients suspected of testicular malignancies with equivocal ultrasound.
高效液相色谱(HPLC)与免疫珠分离技术相结合,用于从一组蛋白质中鉴定单个蛋白质。这一过程使用了针对胎盘碱性磷酸酶(PLAP)的自制单克隆抗体(ATC2)作为与溴化氰珠偶联的一抗。通过比色法(MEDC)测定PLAP的磷酸酶活性(ALP)。该研究的数据迄今表明:1. 用ATC2偶联珠分离后对分子进行HPLC分析显示出高度的纯度。这可以使用从肿瘤细胞系或肿瘤片段裂解物制备的蛋白质混合物来实现。2. HPLC分离的PLAP保持磷酸酶活性。3. 在使用的四种解离试剂中,发现二乙胺(DEA)是从溴化氰珠上解离抗原(即PLAP)而非单克隆抗体的最佳试剂。4. 从睾丸和肾脏片段制备的样品的ALP活性谱在HPLC峰谱以及灵敏度方面均有所不同。这些数据证实,免疫珠分离技术与HPLC相结合是从一组蛋白质中鉴定单个蛋白质的有力工具。这些方法正用于鉴定PLAP分子,作为超声检查结果不明确的疑似睾丸恶性肿瘤患者的肿瘤标志物。